PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF UPADACITINIB IN CHILDREN WITH ATOPIC DERMATITIS

被引：0
|
作者：
Qian, Y. [1 ]
Raymundo, E. [1 ]
Hao, S. [1 ]
Unnebrink, K. [2 ]
Liu, J. [1 ]
Teixeira, H. [1 ]
Chu, A. [1 ]
Paller, A. [3 ]
Liu, W. [1 ]
Mohamed, M. [1 ]
机构：
[1] AbbVie, N Chicago, IL USA
[2] AbbVie DeutschIand GmbH & Co KG, Ludwigshafen, Germany
[3] Northwestern Univ, Chicago, IL USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2023年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII-114
引用
收藏
页码：S78 / S78
页数：1
相关论文
共 50 条
  • [31] Upadacitinib for Refractory Paediatric Atopic Dermatitis: A Real-World Study on Effectiveness and Safety in Dupilumab Nonresponders
    Zhao, Mutong
    Zhuang, Yi
    Liang, Yuan
    Ma, Lin
    Shen, Chunping
    CLINICAL AND EXPERIMENTAL ALLERGY, 2024, 54 (09): : 694 - 696
  • [32] Effectiveness and safety of upadacitinib retreatment after withdrawal in moderate-to-severe atopic dermatitis: a retrospective study
    Hagino, Teppei
    Saeki, Hidehisa
    Fujimoto, Eita
    Kanda, Naoko
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2024,
  • [33] Efficacy and Safety of Upadacitinib for Management of Moderate-to-Severe Atopic Dermatitis: An Evidence-Based Review
    Lytvyn, Yuliya
    Mufti, Asfandyar
    Abduelmula, Abrahim
    Sachdeva, Muskaan
    Maliyar, Khalad
    Georgakopoulos, Jorge R.
    Yeung, Jensen
    PHARMACEUTICS, 2022, 14 (11)
  • [34] The efficacy and safety of upadacitinib treatment for moderate to severe atopic dermatitis in real-world practice in Japan
    Hagino, Teppei
    Saeki, Hidehisa
    Kanda, Naoko
    JOURNAL OF DERMATOLOGY, 2022, 49 (11): : 1158 - 1167
  • [35] Effectiveness and Safety of Upadacitinib in Combination with Topical Corticosteroids in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis
    Hagino, Teppei
    Hamada, Risa
    Yoshida, Mai
    Fujimoto, Eita
    Saeki, Hidehisa
    Kanda, Naoko
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2023, 16 : 3201 - 3212
  • [36] Periocular molluscum contagiosum in an atopic dermatitis patient treated with upadacitinib
    De Luca, E.
    Gori, N.
    Chiricozzi, A.
    Di Stefani, A.
    Peris, K.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (07) : 3068 - 3069
  • [37] A CASE OF MYCOSIS FUNGOIDES MIMICKING ATOPIC DERMATITIS TREATED WITH UPADACITINIB
    Kook, Hyung Don
    Park, So Yun
    Hong, Narang
    Lee, Dong Heon
    Jung, Hye Jung
    Park, Mi Youn
    Ahn, Jiyoung
    ACTA DERMATO-VENEREOLOGICA, 2022, 102 : 30 - 30
  • [38] Predictive factors for responders to upadacitinib treatment in patients with atopic dermatitis
    Hagino, Teppei
    Yoshida, Mai
    Hamada, Risa
    Saeki, Hidehisa
    Fujimoto, Eita
    Kanda, Naoko
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2024, 35 (01)
  • [39] Upadacitinib for the management of overlapping psoriasis and atopic dermatitis: a case series
    Carlos, Calvo-Asin
    Tous-Romero, Fatima
    Garcia-Donoso, Carmen
    Puig-Buendia, Jose
    Borja, Gonzalez-Rodriguez
    Cavestany-Rodriguez, Raquel
    Rivera-Diaz, Raquel
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2024,
  • [40] Upadacitinib for moderate to severe atopic dermatitis with generalized prurigo nodularis
    Lou, Fanglu
    Wang, Yuyi
    Xiao, Yujuan
    Liu, Yi
    ASIAN JOURNAL OF SURGERY, 2024, 47 (07) : 3084 - 3088
12345